Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Akebia Therapeutics
(NQ:
AKBA
)
3.030
USD
+0.050 (+1.68%)
Official Closing Price
Updated: 7:52 PM EDT, Apr 13, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,452,500
Open
3.020
Bid (Size)
2.960 (2)
Ask (Size)
3.000 (1)
Prev. Close
2.980
Today's Range
2.890 - 3.030
52wk Range
2.090 - 13.71
Shares Outstanding
47,353,166
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Akebia Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
April 12, 2021
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive...
From
PR Newswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2021
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 19 newly-hired employees options to purchase an...
From
PR Newswire
Performance
YTD
+3.77%
+3.77%
1 Month
-15.83%
-15.83%
3 Month
-0.66%
-0.66%
6 Month
-14.65%
-14.65%
1 Year
-56.09%
-56.09%
More News
Read More
Akebia Submits New Drug Application (NDA) to the FDA for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis
March 30, 2021
From
PR Newswire
Akebia Therapeutics Announces Poster Presentations and Educational Symposium at National Kidney Foundation 2021 Virtual Spring Clinical Meetings
March 25, 2021
From
PR Newswire
Akebia Therapeutics Announces Approval for Additional Indication of Riona® (ferric citrate hydrate) for the Treatment of Iron Deficiency Anemia in Adult Patients in Japan
March 24, 2021
From
PR Newswire
Akebia Therapeutics Celebrates World Kidney Day and National Kidney Month
March 11, 2021
From
PR Newswire
4 Penny Stocks On Robinhood You Might’ve Missed This Week
March 19, 2021
Tags
Market News
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 02, 2021
From
PR Newswire
Akebia Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
March 02, 2021
From
PR Newswire
Peek Under The Hood: XBI Has 65% Upside
April 08, 2021
Tags
ETFs
From
ETF Channel
Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Updates
February 25, 2021
From
PR Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.